WHO ICTRP trial
A randomised, double-blind, placebo-controlled, 6-month study of the efficacy…
EUCTR2005-002038-36-AT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-002038-36-AT |
|---|---|
| Public title | A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson’s disease dementia or dementia with Lewy Bodies |
| Scientific title | A randomised, double-blind, placebo-controlled, 6-month study of the efficacy and safety of memantine in patients with Parkinson’s disease dementia or dementia with Lewy Bodies |
| Primary sponsor | H. Lundbeck A/S |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Germany;United Kingdom;France;Spain;Italy;Greece;Austria;Germany;United Kingdom;France;Spain;Italy;Greece;Austria |
| Conditions | Patients with Parkinson’s disease dementia or dementia with Lewy Bodies;Patients with Parkinson’s disease dementia or dementia with Lewy Bodies |
| Interventions | Trade Name: Ebixa Product Name: Ebixa Pharmaceutical Form: Film-coated tablet INN or Proposed INN: MEMANTINE HYDROCHLORIDE Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 10- Pharmaceutical form of the… |
| Registration date | Sep 10, 2006 |
| Target size | 200 |
| Secondary IDs | 11018;N.A.;2005-002038-36-GR;11018;N.A.;2005-002038-36-GR |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: